Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-372.87M
↓ 102% below average
Average (5y)
$-184.26M
Historical baseline
Range
High:$-52.13M
Low:$-372.87M
CAGR
+43.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-372.87M | -24.2% |
| 2023 | $-300.33M | -148.4% |
| 2022 | $-120.88M | +39.1% |
| 2021 | $-198.41M | -280.6% |
| 2020 | $-52.13M | +14.5% |
| 2019 | $-60.95M | - |